Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: A study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial
- Ruiz-Pinto, S.
- Martin, M.
- Pita, G.
- Caronia, D.
- De La Torre-Montero, J.C.
- Moreno, L.T.
- Moreno, F.
- Garciá-Saénz, J.A.
- Benítez, J.
- González-Neira, A.
ISSN: 1744-6880, 1744-6872
Datum der Publikation: 2018
Ausgabe: 28
Nummer: 11
Seiten: 245-250
Art: Artikel